Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/S-Amlodipine FDC vs S-Amlodipine in Stage 2 Hypertension
NCT01983735Phase 3Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Jan 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan in hypertension (HTN), sponsored by Chong Kun Dang Holdings. Status: unknown.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01983735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01983735.